Weight-normalized norepinephrine dosing and apparent BMI-dependent vasopressin responsiveness - Quiz - MDSpire

Weight-normalized norepinephrine dosing and apparent BMI-dependent vasopressin responsiveness

  • By

  • Pedro D. Wendel-Garcia

  • Sebastian Morales

  • Paulo Melo

  • Greta Emilia Kiavialaitis

  • Peter Wohlrab

  • Ricardo Castro

  • Edda Tschernko

  • Glenn Hernández

  • Eduardo Kattan

  • April 14, 2026

  • 0 min

Share

Original Source(s)

Weight-normalized norepinephrine dosing and apparent BMI-dependent vasopressin responsiveness

  • by Pedro D. Wendel-Garcia, Sebastian Morales, Paulo Melo, Greta Emilia Kiavialaitis, Peter Wohlrab, Ricardo Castro, Edda Tschernko, Glenn Hernández, Eduardo Kattan

  • April 14, 2026

Related Content

Editorial: Cardiovascular Anthropometry For Large Scale Population Studies Volume II

Lipidomics Point to Obesity–Alzheimer's Link

Study uses multi-omics tools to examine obesity-related pathways linked to neurodegeneration

  • May 26, 2026

  • 2 min
IPS Could Minimize GI Effects in Treating Iron Deficiency

Review summarizes pharmacokinetic and clinical data on iron protein succinylate across patients with iron deficiency and iron deficiency anemia.